ThetaOwl

NVO AI Analysis Reports

Novo Nordisk A/S

DirectionalTheta GangFlowEarnings
Directional
March 31, 2026

Bearish with a strong gravitational pull to the $35 gamma flip level. Confidence: 8/10. The regime is clearly defined by

Confidence:8/10

Primary thesis: Bearish drift toward $35 support, driven by negative GEX and institutional put hedging. Invalidation is a close above $38.72. The regime favors defined-risk bearish spreads (put spread

Based on market close March 31, 2026
Theta Gang
March 31, 2026

Attractiveness: 8/10

Confidence:7/10

Sell defined-risk put spreads below gamma flip, targeting 30-45 DTE

Based on market close March 31, 2026
Flow
March 31, 2026

Bearish

Confidence:7.5/10

Sustained net premium outflow >$50M and P/C ratio >1.3

Based on market close March 31, 2026
Earnings
March 31, 2026

Earnings expected around May 6th, 36 days out. IV is elevated (53%) with a clear term structure kink at the May 8th expi

Confidence:6.5/10

IV term structure kink at 5/08 (52% vs 43% pre) confirms earnings pricing for early May.

Based on market close March 31, 2026

Browse AI-powered options reports for NVO, including directional, theta gang, flow, and earnings analysis. Each report features regime classification, key price levels, strategy viability ratings, and specific trade recommendations updated daily.